The pharmacokinetics and bioavailability of subcutaneously administered dihydroergotamine, heparin and the dihydroergotamine-heparin combination-Reference-Cited by-同舟云学术

The pharmacokinetics and bioavailability of subcutaneously administered dihydroergotamine, heparin and the dihydroergotamine-heparin combination

Published:1983-07 Issue:1 Volume:31 Page:51-67
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Schran Horst F.,Bitz Douglas W.,Diserio Frank J.,Hirsh Jack

Publisher

Elsevier BV

Subject

Hematology

Reference37 articles.

1. Factors in the initiation of deep venous thrombosis;Wessler,1975

2. Stasis and prevention of deep vein thrombosis;Nicolaides,1972

3. Comparative studies on drugs which increase venous tone using noradrenaline, ethyladrianol, dihydroergotamine and horse chestnut extract;Lange;Fort. Med.,1972

4. A new method for prophylaxis of postoperative venous thrombosis;Muhe;Der Klinikarzt,1972

5. Dihydroergotamine in the prevention of postoperative deep venous thrombosis;Stamatakis;British J. Surgery,1977

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombin–Heparin Complexes;Polymeric Biomaterials;2013-01-17

2. Unfractionated Heparin for the Treatment of Venous Thromboembolism: Best Practices and Areas of Uncertainty;Seminars in Thrombosis and Hemostasis;2012-06-20

3. Improving Blood Compatibility of Biomaterials Using a Novel Antithrombin‚ÄìHeparin Covalent Complex;Biomaterials Fabrication and Processing Handbook;2008-03-27

4. Isoform composition of antithrombin in a covalent antithrombin–heparin complex;Biochemical and Biophysical Research Communications;2003-10

5. Clinically Significant Drug Interactions with Agents Specific For Migraine Attacks;CNS Drugs;2001